WuXi XDC shareholders endorse all AGM resolutions; issuance mandate gains 88.74% support

Bulletin Express
06/26

WuXi XDC Cayman Inc. announced that all seven resolutions proposed at the Annual General Meeting held on 26 June 2026 were approved by poll.

Resolution highlights 1. Acceptance of the audited consolidated financial statements for FY-2025 received 99.996% votes in favor.

2. Board composition was reaffirmed: • Executive Director Jerry Jingwei Zhang was re-elected with 99.78% support. • Non-Executive Director Ming Shi secured 94.08% approval, the lowest support level among the nominees. • Independent Non-Executive Director Ulf Grawunder was re-elected with 98.55% support.

3. Directors’ remuneration for FY-2026 was authorized with 99.08% approval.

4. Deloitte Touche Tohmatsu was re-appointed as external auditor, backed by 94.90% of votes cast.

5. A general mandate allowing the Board to issue, allot and deal with shares (excluding treasury shares) obtained 88.74% support, while the related mandate extension—adding repurchased shares to the issuance limit—was approved by 87.96%.

6. Authority to repurchase shares gained 99.83% approval.

Voting statistics • Total shares outstanding: 1.26 billion. • No treasury or pending-cancellation shares. • Futu Trustee Limited, holding 5.70 million unvested restricted shares under the 2024 Share Scheme, abstained in accordance with Listing Rule 17.05A. • Computershare Hong Kong Investor Services Ltd. acted as scrutineer.

Board attendance Executive Directors Dr. Jincai Li and Mr. Jerry Jingwei Zhang; Non-Executive Directors Dr. Jijie Gu and Ms. Ming Shi; and Independent Non-Executive Directors Dr. Ulf Grawunder and Mr. Kenneth Walton Hitchner III attended the meeting in person or electronically.

All resolutions passed with comfortable margins, maintaining management continuity and securing flexibility for future capital management.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10